Assignee
ADHEREX TECHNOLOGIES INC
CA·27 granted patents·19 pending applications·577 citations·filing 1997–2009
Top patents by PatentIndex Score
46 records- 0195US6569996B1Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequenceADHEREX TECHNOLOGIES INC·Filed 2001·Granted May 27, 2003·50 cites·1 claims
- 0294US7446120B2Peptidomimetic modulators of cell adhesionADHEREX TECHNOLOGIES INC·Filed 2007·Granted Nov 4, 2008·49 cites·5 claims
- 0393US6638911B1Compounds and methods for modulating desmosomal cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2000·Granted Oct 28, 2003·30 cites·14 claims
- 0493US6310177B1Compounds and methods for modulating tissue permeabilityADHEREX TECHNOLOGIES INC·Filed 2000·Granted Oct 30, 2001·39 cites·31 claims
- 0588US6682901B2Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jan 27, 2004·63 cites·2 claims
- 0686US7268115B2Peptidomimetic modulators of cell adhesionADHEREX TECHNOLOGIES INC·Filed 2003·Granted Sep 11, 2007·11 cites·3 claims
- 0786US6391855B1Compounds and methods for modulating junctional adhesion molecule-mediated functionsADHEREX TECHNOLOGIES INC·Filed 1999·Granted May 21, 2002·44 cites·14 claims
- 0885US6962969B2Compounds and methods for modulating nonclassical cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2001·Granted Nov 8, 2005·14 cites·14 claims
- 0983US6806255B2Compounds and methods for modulating adhesion molecule functionADHEREX TECHNOLOGIES INC·Filed 2002·Granted Oct 19, 2004·12 cites·7 claims
- 1082US6677116B1Methods for treating cancer by modulating β-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 2000·Granted Jan 13, 2004·14 cites·13 claims
- 1181US6472368B1Compounds and methods for modulating adhesion molecule functionADHEREX TECHNOLOGIES INC·Filed 1999·Granted Oct 29, 2002·34 cites·3 claims
- 1281US6110747ACompounds and methods for modulating tissue permeabilityADHEREX TECHNOLOGIES INC·Filed 1998·Granted Aug 29, 2000·38 cites·9 claims
- 1380US7122623B2Compounds and methods for modulating cell adhesionADHEREX TECHNOLOGIES INC·Filed 2003·Granted Oct 17, 2006·4 cites·3 claims
- 1479US7456153B2Compounds and methods for modulating functions of classical cadherinsADHEREX TECHNOLOGIES INC·Filed 2003·Granted Nov 25, 2008·9 cites·9 claims
- 1576US6433149B1Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 1999·Granted Aug 13, 2002·33 cites·10 claims
- 1675US6303576B1Compounds and methods for modulating β-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 1999·Granted Oct 16, 2001·30 cites·25 claims
- 1774US7476509B2Compounds and methods for modulating functions of nonclassical cadherinsADHEREX TECHNOLOGIES INC·Filed 2003·Granted Jan 13, 2009·5 cites·5 claims
- 1874US6472367B1Compounds and methods for modulating OB-cadherin mediated cell adhesionADHEREX TECHNOLOGIES INC·Filed 1998·Granted Oct 29, 2002·22 cites·14 claims
- 1974US6248864B1Compounds and methods and modulating tissue permeabilityADHEREX TECHNOLOGIES INC·Filed 1997·Granted Jun 19, 2001·24 cites·17 claims
- 2066US6830894B1Compounds and methods for modulating claudin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 1999·Granted Dec 14, 2004·21 cites·8 claims
- 2166US2004248220A1Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 2263US6706685B1Compounds and methods for stimulating β-catenin mediated gene expression and differentiationADHEREX TECHNOLOGIES INC·Filed 2000·Granted Mar 16, 2004·1 cites·11 claims
- 2362US7481999B2Compounds and methods for modulating OB-cadherin-mediated functionADHEREX TECHNOLOGIES INC·Filed 2004·Granted Jan 27, 2009·0 cites·3 claims
- 2461US2007203057A1Compounds and methods for modulating adhesion molecule functionADHEREX TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 2560US2004229811A1Compounds and methods for modulating desmosomal cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 2660US2005037973A1Compounds and methods for cancer therapyADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 2759US2009291967A1Small molecule modulators of cell adhesionADHEREX TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 2859US2005163786A1Compounds and methods for modulating adhesion molecule functionADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 2958US2009196833A1Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndromeADHEREX TECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 3057US2005203025A1Compounds and methods for modulating nonclassical cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 3156US2008255168A1Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugsADHEREX TECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 3256US2003027761A1Compounds and methods for modulating junctional adhesion molecule-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 3356US2008194467A1Cancer treatment methods using cadherin antagonists in combination with anticancer agentsADHEREX TECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 3456US2003229199A1Compounds and methods for modulating nonclassical cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 3555US6723700B1Compounds and methods for modulating claudin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 1999·Granted Apr 20, 2004·6 cites·5 claims
- 3655US2005222037A1Compounds and methods for modulating VE-cadherin-mediated functionADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 3753US2004254099A1Compounds and methods for modulating beta-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 3851US2004142854A1Compounds and methods for stimulating beta-catenin mediated gene expression and differentiationADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 3951US2006183884A1Compounds and methods for modulating cell adhesionADHEREX TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 4050US6797807B1Compounds and methods for cancer therapyADHEREX TECHNOLOGIES INC·Filed 1999·Granted Sep 28, 2004·7 cites·21 claims
- 4150US6680175B2Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jan 20, 2004·10 cites·6 claims
- 4248US2009131306A1Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses thereforADHEREX TECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 4347US2003096746A1Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 4446US6593297B2Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jul 15, 2003·7 cites·14 claims
- 4534US6756356B2Compounds and methods for modulating claudin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 1998·Granted Jun 29, 2004·0 cites·6 claims
- 4633US2004248219A1Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →